The research of miR-301 in gastric cancer cell proliferation and apoptosis

We investigated the impact and mechanisms of miR-301 in gastric cancer cell proliferation and apoptosis, and looked forward to find a new frame of reference in the clinical diagnosis and treatment. 100 case gastric carcinoma collected from our hospital gastrointestinal surgery were as the observation group (group A); then collected 100 cases of carcinoma adjacent as the negative control group (group B) and 10 healthy adult normal gastric cell line (GES-1) as the healthy control group (group C). Used real-time PCR to analyze the miR-301 expression of the three groups, MTT assay detect cell proliferation, annexin V/PI staining detect cell apoptosis, TargetScans software predict target genes, then used luciferase reporter gene assay to verify the predicted target genes. Western blot was used to detect the predicted miR-301 target gene expression. The results showed that miR-301 expression from the observation group was significantly higher than the negative control group and the healthy control group (P < 0.05). The absorbance values measured showed that the observation group was significantly higher than the other two groups (P < 0.05). After transfection anti-miR-301, MGC-803 apoptosis index was significantly higher than (NC) group and control (Ctr) group (P < 0.05). MiR-301 expression was positively correlated with tumor size, TNM staging and Lauren type, and it had no correlation with gender, age, lymph node metastasis and tissue differentiation. Targetsscan software predicted the target gene of miR-301 may be PTEN, which was confirmed by luciferase reporter assay. Western blot showed that transfection of miR-301 mimic significantly inhibited the expression of PTEN in MGC-803 cells (P < 0.01), whereas transfection anti-miR-301 could significantly increase the PTEN expression (P < 0.01). MiR-301 upregulated in gastric cancer, high expression of miR-301 may be involved in the occurrence and development of gastric cancer by adjusting the target gene PTEN.

[1]  G. Sauter,et al.  The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion , 2015, BMC Cancer.

[2]  Jun-quan Yang,et al.  Expression of p27 and PTEN and clinical characteristics in early laryngeal squamous cell carcinoma and their correlation with recurrence. , 2015, International journal of clinical and experimental pathology.

[3]  K. Yanaga,et al.  MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells. , 2014, International journal of oncology.

[4]  Zhen Liu,et al.  Overexpression of GNAO1 correlates with poor prognosis in patients with gastric cancer and plays a role in gastric cancer cell proliferation and apoptosis. , 2014, International journal of molecular medicine.

[5]  Eva E. Rufino-Palomares,et al.  MicroRNAs as Oncogenes and Tumor Suppressors , 2013 .

[6]  Yugang Wang,et al.  Regulation of Id1 expression by epigallocatechin-3-gallate and its effect on the proliferation and apoptosis of poorly differentiated AGS gastric cancer cells , 2013, International journal of oncology.

[7]  J. Ju,et al.  Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer , 2013, Journal of Gastroenterology.

[8]  Ying-Peng Huang,et al.  Potentially predictive microRNAs of gastric cancer with metastasis to lymph node. , 2011, World journal of gastroenterology.

[9]  Anthony Fyles,et al.  MicroRNA-301 mediates proliferation and invasion in human breast cancer. , 2011, Cancer research.

[10]  W. Guo,et al.  [Effects of Xiaotan Sanjie Decoction-containing serum on proliferation and apoptosis of human gastric cancer cells MKN-45]. , 2010, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[11]  J. Bertino,et al.  MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. , 2009, Pharmacogenomics.

[12]  N. Lynam‐Lennon,et al.  The roles of microRNA in cancer and apoptosis , 2009, Biological reviews of the Cambridge Philosophical Society.

[13]  Jan-Fang Cheng,et al.  Dicer, Drosha, and outcomes in patients with ovarian cancer. , 2008, The New England journal of medicine.

[14]  Gui-ying Zhang,et al.  [Effect of a selective COX-2 inhibitor on cell proliferation and apoptosis in human gastric cancer cell line BGC-823]. , 2008, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[15]  R. Seruca,et al.  Molecular targets and biological modifiers in gastric cancer. , 2008, Seminars in diagnostic pathology.

[16]  C. Lee,et al.  MicroRNA and cancer – focus on apoptosis , 2008, Journal of cellular and molecular medicine.

[17]  Thomas D. Schmittgen,et al.  Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.

[18]  Thomas D. Schmittgen,et al.  Expression profiling identifies microRNA signature in pancreatic cancer , 2006, International journal of cancer.

[19]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[20]  A. Tarnawski,et al.  MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth. , 2001, Life sciences.

[21]  M. Morita,et al.  Depressed type of intramucosal differentiated-type gastric cancer has high cell proliferation and reduced apoptosis compared with the elevated type , 2012, Gastric Cancer.

[22]  R. Russell,et al.  Lycopene supplementation prevents smoke-induced changes in p53, p53 phosphorylation, cell proliferation, and apoptosis in the gastric mucosa of ferrets. , 2006, The Journal of nutrition.